These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 27563020)

  • 21. Experimental models to study cholangiocyte biology.
    Tietz PS; Chen XM; Gong AY; Huebert RC; Masyuk A; Masyuk T; Splinter PL; LaRusso NF
    World J Gastroenterol; 2002 Feb; 8(1):1-4. PubMed ID: 11833061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium signaling and the secretory activity of bile duct epithelia.
    Amaya MJ; Nathanson MH
    Cell Calcium; 2014 Jun; 55(6):317-24. PubMed ID: 24612866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholangiocytes derived from induced pluripotent stem cells for disease modeling.
    Ghanekar A; Kamath BM
    Curr Opin Gastroenterol; 2016 May; 32(3):210-5. PubMed ID: 27054776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biliary differentiation and bile duct morphogenesis in development and disease.
    Raynaud P; Carpentier R; Antoniou A; Lemaigre FP
    Int J Biochem Cell Biol; 2011 Feb; 43(2):245-56. PubMed ID: 19735739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium signaling and secretion in cholangiocytes.
    Guerra MT; Nathanson MH
    Pancreatology; 2015 Jul; 15(4 Suppl):S44-8. PubMed ID: 26100660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver.
    Alvaro D; Mancino MG; Glaser S; Gaudio E; Marzioni M; Francis H; Alpini G
    Gastroenterology; 2007 Jan; 132(1):415-31. PubMed ID: 17241889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Cholangiocyte Glycocalyx Stabilizes the 'Biliary HCO3 Umbrella': An Integrated Line of Defense against Toxic Bile Acids.
    Maillette de Buy Wenniger LJ; Hohenester S; Maroni L; van Vliet SJ; Oude Elferink RP; Beuers U
    Dig Dis; 2015; 33(3):397-407. PubMed ID: 26045275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current strategies to generate mature human induced pluripotent stem cells derived cholangiocytes and future applications.
    Cervantes-Alvarez E; Wang Y; Collin de l'Hortet A; Guzman-Lepe J; Zhu J; Takeishi K
    Organogenesis; 2017 Jan; 13(1):1-15. PubMed ID: 28055309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dynamic biliary epithelia: molecules, pathways, and disease.
    O'Hara SP; Tabibian JH; Splinter PL; LaRusso NF
    J Hepatol; 2013 Mar; 58(3):575-82. PubMed ID: 23085249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholangiocyte pathobiology.
    Banales JM; Huebert RC; Karlsen T; Strazzabosco M; LaRusso NF; Gores GJ
    Nat Rev Gastroenterol Hepatol; 2019 May; 16(5):269-281. PubMed ID: 30850822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myofibroblasts control the proliferation of fetal hepatoblasts and their differentiated cholangiocytes during the hepatoblast-to-cholangiocyte transition.
    Wang W; Wan L; Chen Z; Jin X; Li D
    Biochem Biophys Res Commun; 2020 Feb; 522(4):845-851. PubMed ID: 31801666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioengineered bile ducts recapitulate key cholangiocyte functions.
    Chen C; Jochems PGM; Salz L; Schneeberger K; Penning LC; van de Graaf SFJ; Beuers U; Clevers H; Geijsen N; Masereeuw R; Spee B
    Biofabrication; 2018 Jun; 10(3):034103. PubMed ID: 29848792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipopolysaccharide (LPS)-Induced Biliary Epithelial Cell NRas Activation Requires Epidermal Growth Factor Receptor (EGFR).
    Trussoni CE; Tabibian JH; Splinter PL; O'Hara SP
    PLoS One; 2015; 10(4):e0125793. PubMed ID: 25915403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional heterogeneity of cholangiocytes.
    Marzioni M; Glaser SS; Francis H; Phinizy JL; LeSage G; Alpini G
    Semin Liver Dis; 2002 Aug; 22(3):227-40. PubMed ID: 12360417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholangiocyte biology.
    Tietz PS; Larusso NF
    Curr Opin Gastroenterol; 2006 May; 22(3):279-87. PubMed ID: 16550043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue-Engineered Bile Ducts for Disease Modeling and Therapy.
    Wang Z; Faria J; Penning LC; Masereeuw R; Spee B
    Tissue Eng Part C Methods; 2021 Feb; 27(2):59-76. PubMed ID: 33267737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of β-catenin in development of bile ducts.
    Cordi S; Godard C; Saandi T; Jacquemin P; Monga SP; Colnot S; Lemaigre FP
    Differentiation; 2016; 91(1-3):42-9. PubMed ID: 26856660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma.
    Celli A; Que FG
    Semin Liver Dis; 1998; 18(2):177-85. PubMed ID: 9606814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation of chemically induced liver progenitor cells to cholangiocytes: Investigation of the optimal conditions.
    Huang Y; Sakai Y; Hara T; Katsuda T; Ochiya T; Gu WL; Miyamoto D; Hamada T; Kanetaka K; Adachi T; Eguchi S
    J Biosci Bioeng; 2020 Nov; 130(5):545-552. PubMed ID: 32782195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autophagy and senescence in fibrosing cholangiopathies.
    Nakanuma Y; Sasaki M; Harada K
    J Hepatol; 2015 Apr; 62(4):934-45. PubMed ID: 25435435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.